Biolink Influenza A&B + Covid 19

AusMed Health is pleased to be a major distribution partner.

The COVID-19 Rapid Antigen Saliva Pen is an easy-to-use, non-invasive device enabling rapid testing anytime, anywhere.

2025 Expiry Date

PRODUCT NAME

NEW Biolink Ecotest Influenza A & B + COVID-19 Rapid Antigen Test Pen

In order to satisfy TGA requirements, all health care professionals are required to provide their AHPRA number prior to purchasing and undergo self certification by watching the training video below:

Link to Video

STANDARDS ACHIEVED

• Point of care test for medical professionals 

AusMedHealth is proud to announce the launch of its Ecotest Influenza A/B + COVID-19 Rapid Antigen Test Pen in Australia.

This revolutionary product is designed to detect and differentiate the SARS-CoV-2, influenza virus A, and influenza virus B quickly and accurately.  

It is a convenient solution for individuals and healthcare professionals alike, with an innovative design that allows for simple 2-step testing using a single swab. 

With its user-friendly test procedure, the Ecotest Influenza A/B + COVID-19 Rapid Antigen Test Pen offers superior reliability by minimising potential for cross– contamination.
 
Currently only available to point of care facilities AusMedHealth is working to bring a consumer version of this product to market over the coming months – as an ideal solution for those who require fast results, without having to wait in long lines at a testing facility or pharmacy. 

We are committed to providing high-quality products that make testing more accessible and accurate than ever before. Our Influenza A/B + COVID-19 Rapid Antigen Test Pen is the latest example of our commitment to providing innovative healthcare solutions that can make a positive difference in people's lives.